Corteva (CTVA) Tops Q2 EPS by 18c, Offers Guidance
Get Alerts CTVA Hot Sheet
Join SI Premium – FREE
Corteva (NYSE: CTVA) reported Q2 EPS of $1.64, $0.18 better than the analyst estimate of $1.46. Revenue for the quarter came in at $6.35 billion versus the consensus estimate of $6.09 billion.
GUIDANCE:
Corteva sees 2022 EPS of $2.45-$2.60, versus the consensus of $2.50. Corteva sees 2022 revenue of $17.2-17.5 billion, versus the consensus of $16.94 billion.
For earnings history and earnings-related data on Corteva (CTVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Phoenix Education Partners, Inc. (PXED) Misses Q4 EPS by 44c ; Offers Guidance
- Spyre Therapeutics, Inc. (SYRE) Misses Q3 EPS by 16c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share